| 11766434 |
Pyrimidinone derivatives as CDC7 inhibitors |
Emma Carswell, Mark David Charles, Chukuemeka Tennyson Ekwuru, Frederic Elustondo, Katherine M. Fowler +4 more |
2023-09-26 |
|
| 11109801 |
Method of measuring efficacy of treatment for an autoimmune disease in vivarium animals |
Laura Schaevitz |
2021-09-07 |
$92,524,000 |
| RE48622 |
Therapeutically active pyrazolo-pyrimidine derivatives |
Richard Jeremy Franklin, Anant Ramrao Ghawalkar, Helen Tracey Horsley, Qiuya Huang, James Thomas Reuberson +1 more |
2021-07-06 |
|
| 11033494 |
Apparatuses containing an emulsion and methods of manufacture |
Jonathan Betts-LaCroix, Laura Schaevitz |
2021-06-15 |
$121,651,000 |
| 11020396 |
Pyrimidinone derivatives as Cdc7 inhibitors |
Emma Carswell, Mark David Charles, Chukuemeka Tennyson Ekwuru, Frederic Elustondo, Katherine M. Fowler +4 more |
2021-06-01 |
|
| 10959398 |
Experimental animal behavioral research methods and apparatuses |
Jonathan Betts-LaCroix, Laura Schaevitz, Kyle Howard Heath |
2021-03-30 |
|
| 10789432 |
Tracklets |
Kyle Howard Heath, Youssef Barhomi, Pablo Jadzinsky, Jonathan Betts-LaCroix |
2020-09-29 |
|
| 10596198 |
Devices for selectively releasing volatile compounds |
Jonathan Betts-LaCroix, Laura Schaevitz |
2020-03-24 |
|
| 10568567 |
Method of drug approval using motion vector analysis |
Jonathan Betts-LaCroix |
2020-02-25 |
|
| 10506986 |
Method of predicting severity of multiple sclerosis |
Laura Schaevitz |
2019-12-17 |
|
| 10420503 |
Method of measuring efficacy of treatment for multiple sclerosis |
Laura Schaevitz |
2019-09-24 |
|
| 10275686 |
Method of reading arbitrary symbols |
Jonathan Betts-LaCroix |
2019-04-30 |
|
| 10244979 |
Method of early detection of multiple sclerosis |
Laura Schaevitz |
2019-04-02 |
|
| 10188321 |
Method of measuring animal health using motion vector analysis |
Jonathan Betts-LaCroix |
2019-01-29 |
|
| 10176397 |
Method of reading degraded symbols |
Jonathan Betts-LaCroix |
2019-01-08 |
|
| 10087180 |
Pyrazolo-pyridine derivatives as kinase inhibitors |
James Thomas Reuberson |
2018-10-02 |
|
| 9969748 |
Fused bicyclic heteroaromatic derivatives as kinase inhibitors |
Qiuya Huang, Judi Charlotte Neuss, James Thomas Reuberson, Bart Vanderhoydonck |
2018-05-15 |
|
| 9714248 |
Therapeutically active pyrazolo-pyrimidine derivatives |
Richard Jeremy Franklin, Anant Ramrao Ghawalkar, Helen Tracey Horsley, Qiuya Huang, James Thomas Reuberson +1 more |
2017-07-25 |
|
| 9700257 |
Method of measuring gut transit time in animals |
Jonathan Betts-LaCroix, Laura Schaevitz |
2017-07-11 |
|
| 9382263 |
Therapeutically active oxazoline derivatives |
Claire Louise Kulisa, Daniel Christopher Brookings, Richard Jeremy Franklin, James Thomas Reuberson, Anant Ramrao Ghawalkar |
2016-07-05 |
|
| 9227984 |
Therapeutically active fused pyrimidine derivatives |
Daniel Christopher Brookings, Anant Ramrao Ghawalkar, Jean Herman, Qiuya Huang, Claire Louise Kulisa +4 more |
2016-01-05 |
|
| 9126979 |
Compounds for inhibiting the interaction of BCL2 with binding partners |
John Robert Porter, Michael Scott Visser, Naeem Yusuff |
2015-09-08 |
$15,947,000 |
| 9096614 |
Therapeutically active thiazolo-pyrimidine derivatives |
Daniel Christopher Brookings, Richard Jeremy Franklin, Anant Ramrao Ghawalkar, Claire Louise Kulisa, Judi Charlotte Neuss +1 more |
2015-08-04 |
|
| 9029392 |
Quinoline derivatives as kinase inhibitors |
Andrew Harry Parton, Mezher Hussein Ali, Daniel Christopher Brookings, Julien Alistair Brown, Richard Jeremy Franklin +3 more |
2015-05-12 |
|
| 8423517 |
System and method for determining the age of objects in the presence of unreliable clocks |
Alexander Kesselman, Alexandre Drobychev |
2013-04-16 |
$31,662,000 |
